Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL30916083

COc1cc(OC)nc(C[C@@H](N)COc2ccc3ncc(F)cc3c2C(=O)OCc2ccccc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
HSD17B10 Q99714 2/20 0.35
RAB9A P51151 1/20 0.35
MAPK10 P53779 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PDPK1 O15530 5/20 0.35
RPS6KB1 P23443 5/20 0.35
AKT1 P31749 5/20 0.35
PLA2G2A P14555 1/20 0.35
DHODH Q02127 2/20 0.34
OPRK1 P41145 2/20 0.33
PRKCZ Q05513 1/20 0.33
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL30916021 0.91 LMNA (0.35) LMNAHSD17B10RAB9AMAPK10SMN1; SMN2
Trifluoroacetic Acid SCHEMBL30916049 0.91 DHODH (0.36) LMNAHSD17B10RAB9AMAPK10SMN1; SMN2
Hydrochloric Acid SCHEMBL29828357 0.86 SCN4A (0.39) PDPK1RPS6KB1AKT1PLA2G2ADHODH
Hydrochloric Acid SCHEMBL29097073 0.86 SCN4A (0.39) PDPK1RPS6KB1AKT1PLA2G2ADHODH
Hydrochloric Acid SCHEMBL29828403 0.86 SCN4A (0.39) PDPK1RPS6KB1AKT1PLA2G2ADHODH
Hydrochloric Acid SCHEMBL29096946 0.86 SCN4A (0.39) PDPK1RPS6KB1AKT1PLA2G2ADHODH
Hydrochloric Acid SCHEMBL29096949 0.86 SCN4A (0.39) PDPK1RPS6KB1AKT1PLA2G2ADHODH
Hydrochloric Acid SCHEMBL30916089 0.85 LMNA (0.36) LMNAHSD17B10RAB9AMAPK10SMN1; SMN2
Hydrochloric Acid SCHEMBL30916051 0.85 AKT1 (0.36) LMNAHSD17B10RAB9AMAPK10SMN1; SMN2
Trifluoroacetic Acid SCHEMBL30916066 0.83 PPARG (0.33) LMNAHSD17B10RAB9AMAPK10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260098060-A1 MACROCYCLIC CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2026-04-09 US disclosed
EP-4587443-A1 MACROCYCLIC CFTR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2025-07-23 EP disclosed
WO-2024056798-A1 MACROCYCLIC CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098060-A1 MACROCYCLIC CFTR MODULATORS CFTR, CLIC1, ARRB1 LMNA 2343/4885HSD17B10 2897/4885RAB9A 1593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.